Search Results - "de Almeida, Anderson Rodrigues"
-
1
Development, Characterization, and Immunomodulatory Evaluation of Carvacrol-loaded Nanoemulsion
Published in Molecules (Basel, Switzerland) (25-06-2021)“…Carvacrol (CV) is an essential oil with numerous therapeutic properties, including immunomodulatory activity. However, this effect has not been studied in…”
Get full text
Journal Article -
2
IL-17 and related cytokines involved in systemic sclerosis: Perspectives
Published in Autoimmunity (Chur, Switzerland) (02-01-2018)“…Systemic sclerosis (SSc) is a multisystemic, complex, and rare disease of connective tissue, with high morbidity and mortality, and without specific treatment…”
Get full text
Journal Article -
3
CCL3, IL‐7, IL‐13 and IFNγ transcripts are increased in skin's biopsy of systemic sclerosis
Published in Experimental dermatology (01-10-2019)“…Although several cytokines and chemokines have been investigated as possible mediators of fibrosis in systemic sclerosis (SSc), specific correlation between…”
Get full text
Journal Article -
4
Interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29)
Published in Autoimmunity (Chur, Switzerland) (03-10-2015)“…Background: Interferon (IFN)-λ1 is a newly described cytokine, member of type III interferons family, which is known for its antiviral, anti-proliferative and…”
Get full text
Journal Article -
5
IBPA a mutual prodrug of ibuprofen and acetaminophen alleviates inflammation, immune dysregulation and fibrosis in preclinical models of systemic sclerosis
Published in International immunopharmacology (30-07-2024)“…•Synthesis of ibuprofen + paracetamol hybrid mutual prodrug (IBPA)•IBPA promoted reduction in cytokine secretion in PBMC culture supernatant from SSc…”
Get full text
Journal Article -
6
Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations
Published in Immunology letters (01-06-2018)“…•Immune dysregulation is a central process in the pathogenesis of SSc.•In SSc, unstimulated PBMCs produce higher cytokines levels than controls.•The response…”
Get full text
Journal Article -
7
Genetic variants in LGALS3 are related to lower galectin-3 serum levels and clinical outcomes in systemic sclerosis patients: A case-control study
Published in Autoimmunity (Chur, Switzerland) (19-05-2021)“…Systemic sclerosis (SSc) is a rare complex disease characterized by vascular damage, autoimmunity, and extensive skin and internal organs fibrosis. Galectin-3…”
Get full text
Journal Article -
8
Reassessing the Role of the Active TGF- β 1 as a Biomarker in Systemic Sclerosis: Association of Serum Levels with Clinical Manifestations
Published in Disease markers (2016)“…Objective . To determine active TGF- β 1 (aTGF- β 1) levels in serum, skin, and peripheral blood mononuclear cell (PBMC) culture supernatants and to understand…”
Get full text
Journal Article -
9
Statins Inhibit Cytokines in a Dose-Dependent Response in Patients with Systemic Sclerosis
Published in Inflammation (01-04-2019)“…Although statins have been successfully administered in the treatment of hypercholesterolemia and cardiovascular disease due to their lipid-lowering and…”
Get full text
Journal Article -
10
Correction to: Statins Inhibit Cytokines in a Dose-Dependent Response in Patients with Systemic Sclerosis
Published in Inflammation (01-04-2019)“…One of the author’s surname was incorrect. Anderson Ferreira de Almeida should be captured as Anderson Rodrigues de Almeida. The correct name is now presented…”
Get full text
Journal Article -
11
Treatment with biological therapy is associated with faster recovery and lower frequency of treatment switch among rheumatic patients with Chikungunya fever
Published in Advances in rheumatology (London, England) (14-11-2022)“…The effects of Chikungunya virus (CHIKV) infection on patients with rheumatic diseases have not been extensively studied. Our aim was to compare the clinical…”
Get full text
Journal Article -
12
Reassessing the Role of the Active TGF-β1 as a Biomarker in Systemic Sclerosis: Association of Serum Levels with Clinical Manifestations
Published in Disease markers (01-01-2016)“…Objective. To determine active TGF-β1 (aTGF-β1) levels in serum, skin, and peripheral blood mononuclear cell (PBMC) culture supernatants and to understand…”
Get full text
Journal Article -
13
Evaluation of long-term stability of SARS-CoV-2 nucleic acid extracted from human nasopharyngeal samples
Published in Journal of virological methods (01-07-2022)“…The maintenance of SARS-Cov-2 RNA samples poses a new challenge for laboratories and researchers. In addition, it is a requirement in order to identify what…”
Get full text
Journal Article -
14
Sensitivity and specificity of Interleukin 29 in patients with rheumatoid arthritis and other rheumatic diseases
Published in Immunology letters (01-04-2020)“…•Patients with rheumatoid arthritis (RA) have high serum levels of IL-29.•Serum IL-29 levels correlate with rheumatoid factor and absolute neutrophil…”
Get full text
Journal Article -
15
Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters
Published in Immunobiology (1979) (01-05-2020)“…•sOSMR and sgp130 serum levels are increased in patients with systemic sclerosis.•sOSMR levels are associated with the presence of digital ulcers in SSc…”
Get full text
Journal Article -
16
Design, synthesis and pharmacological evaluation of CVIB, a codrug of carvacrol and ibuprofen as a novel anti-inflammatory agent
Published in International immunopharmacology (01-11-2019)“…The search for new drugs with anti-inflammatory properties remains a challenge for modern medicine. Among the various strategies for drug discovery, deriving…”
Get full text
Journal Article -
17
PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients
Published in Inflammopharmacology (01-02-2024)“…Thiazolidinediones (TZD) are synthetic molecules that have a range of biological effects, including antifibrotic and anti-inflammatory, and they may represent…”
Get full text
Journal Article -
18
Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients
Published in Inflammopharmacology (01-08-2019)“…Glucocorticoids (GC) are widely used in the treatment of SSc, although there is not much evidence to prove the benefits offered by these drugs in this disease…”
Get full text
Journal Article -
19
Corticosteroid inhibits chemokines production in systemic sclerosis patients
Published in Steroids (01-11-2017)“…•Methylprednisolone inhibited CCL2, CCL5 and CXCL8 production by scleroderma PBMC.•No effect was observed on IL-2, IL-4, IL-6, IL-10, IL-17A, TFN and IFN-γ…”
Get full text
Journal Article -
20
Reassessing the role of the active TGF-[beta]1 as a biomarker in systemic sclerosis: association of serum levels with clinical manifestations
Published in Disease markers (01-01-2016)Get full text
Journal Article